Allergy; Case report; diabetes; Insulin; Metacresol
Abstract :
[en] Since the introduction of human insulin, the incidence of allergic reactions has decreased from 50% to 1%-2.4%. The culprit may be insulin or an excipient.
Disciplines :
Dermatology
Author, co-author :
COLSON, Fany ; Centre Hospitalier Universitaire de Liège - CHU > Autres Services Médicaux > Service de dermatologie
NIKKELS, Arjen ; Centre Hospitalier Universitaire de Liège - CHU > Autres Services Médicaux > Service de dermatologie
DEZFOULIAN, Bita ; Centre Hospitalier Universitaire de Liège - CHU > Autres Services Médicaux > Service de dermatologie
Language :
English
Title :
Allergy to metacresol in a type 2 diabetes patient
Alternative titles :
[en] Allergie au métacrésol chez un patient diabétique de type 2
Kim D, Baraniuk J. Delayed-type hypersensitivity reaction to the meta-cresol component of insulin. Ann Allergy Asthma Immunol. 2007;99(2):194-195.
Wheeler BJ, Taylor BJ. Successful management of allergy to the insulin excipient metacresol in a child with type I diabetes: a case report. J Med Case Rep. 2012;6:263.
Clerx V, van den Keybus C, Kochuyt A, Goosens A. Drug intolerance reaction to insulin therapy caused by metacresol. Contact Dermatitis. 2003;48(3):162-163.
Rajpar SF, Foulds IS, Abdullah A, Maheshwari M. Severe adverse cutaneous reaction due to cresol sensitivity. Contact Dermatitis. 2006;55(2):119-120.
Radermecker RP, Scheen AJ. Allergy reactions to insulin: effects of continuous subcutaneous insulin infusion and insulin analogues. Diabetes Metab Res Rev. 2007;23(5):348-355.
Asai M, Yoshida M, Miura Y. Immunologic tolerance to intravenously injected insulin. N Engl J Med. 2006;354(3):307-309.
